Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Assembly Biosciences, Inc. (ASMB) had Return on Equity of -5.03% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$10.79M |
|
$-9.20M |
|
-- |
|
$10.79M |
|
$21.67M |
|
$-10.88M |
|
$1.69M |
|
$-9.20M |
|
$-9.20M |
|
$-9.20M |
|
$-9.20M |
|
$-9.20M |
|
$-9.20M |
|
$-10.88M |
|
$-11.48M |
|
12.69M |
|
12.69M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$236.81M |
|
$0.23M |
|
$3.19M |
|
$240.00M |
|
$53.38M |
|
-- |
|
$3.92M |
|
$57.30M |
|
$182.69M |
|
$182.69M |
|
$182.69M |
|
15.82M |
|
| Cash Flow Statement Financials | |
$-55.33M |
|
$-134.69M |
|
$174.21M |
|
$38.34M |
|
$22.53M |
|
$-15.81M |
|
$3.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-100.87% |
|
-100.87% |
|
-- |
|
-85.23% |
|
-85.23% |
|
$-55.37M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
11.83 |
|
7.61 |
|
|
Return on Equity |
-5.03% |
-5.03% |
|
-3.83% |
|
-5.03% |
|
$11.55 |
|
$-4.36 |
|
$-4.36 |
|